X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-02 | KYMR | Gollob Jared | Chief Medical Officer | S - Sale+OE | $87.24 | -10,508 | 117,134 | -8% | -$916,669 | |||||
| D | 2025-12-08 | KYMR | Gollob Jared | Chief Medical Officer | S - Sale+OE | $88.67 | -49,307 | 109,992 | -31% | -$4,371,833 | |||||
| D | 2025-10-15 | KYMR | Gollob Jared | Chief Medical Officer | S - Sale+OE | $61.42 | -59,576 | 109,992 | -35% | -$3,659,254 | |||||
| D | 2025-10-13 | KYMR | Gollob Jared | Chief Medical Officer | S - Sale+OE | $60.00 | -3,114 | 118,359 | -3% | -$186,840 | |||||
| D | 2025-03-03 | KYMR | Gollob Jared | Chief Medical Officer | S - Sale+OE | $30.45 | -5,740 | 120,000 | -5% | -$174,786 | |||||
| DM | 2024-07-15 | KYMR | Gollob Jared | Chief Medical Officer | S - Sale+OE | $45.53 | -39,600 | 95,470 | -29% | -$1,803,143 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |